67 related articles for article (PubMed ID: 25346303)
1. Case of acrodermatitis continua of Hallopeau following psoriasis with atypical clinical presentation.
Iijima S; Okazaki Y; Watanabe S; Maruyama Y
J Dermatol; 2014 Nov; 41(11):1006-8. PubMed ID: 25346303
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report.
Wen P; Liu C; Wang T; Jiang X; Wang P; Wang S
Front Immunol; 2024; 15():1338285. PubMed ID: 38464535
[TBL] [Abstract][Full Text] [Related]
3. Spesolimab Response in a Girl With Acrodermatitis Continua of Hallopeau.
Wang Y; Zhang L; Zheng J; Li X; Chen L
JAMA Dermatol; 2024 Apr; 160(4):476-477. PubMed ID: 38416455
[TBL] [Abstract][Full Text] [Related]
4. A retrospective analysis of 65 patients with acrodermatitis continua of Hallopeau.
Chularojanamontri L; Silpa-Archa N; Pattamadilok B; Julanon N; Chuamanochan M; Pongcharoen P; Lertphanichkul C; Asawanonda P
Exp Dermatol; 2024 Mar; 33(3):e15055. PubMed ID: 38519437
[TBL] [Abstract][Full Text] [Related]
5. Pustular psoriasis: A distinct aetiopathogenic and clinical entity.
Vasudevan B; Das P; Bhatt S
Indian J Dermatol Venereol Leprol; 2023 [SEASON]; 90(1):19-29. PubMed ID: 37317717
[TBL] [Abstract][Full Text] [Related]
6. Anti-Interleukin-17s for successful management of pustular psoriasis.
Guerra P; Rosi E; Scandagli I; Silvi G; Nunziati G; Di Cesare A; Prignano F
Cytokine; 2023 Nov; 171():156353. PubMed ID: 37672865
[TBL] [Abstract][Full Text] [Related]
7. Pustular psoriasis: pathophysiology and current treatment perspectives.
Benjegerdes KE; Hyde K; Kivelevitch D; Mansouri B
Psoriasis (Auckl); 2016; 6():131-144. PubMed ID: 29387600
[TBL] [Abstract][Full Text] [Related]
8. Paediatric acrodermatitis continua of Hallopeau: perspectives of a patient and their mother.
O'Malley S; Duff E; Collins S
Clin Exp Dermatol; 2023 Dec; 49(1):92-93. PubMed ID: 37758513
[No Abstract] [Full Text] [Related]
9. Local injection of micro-dose guselkumab for acrodermatitis continua of Hallopeau after failure of systemic ixekizumab treatment.
Wang Y; Zhou C; Hou Y; Diao Z; Chen D; Yin Z
Int J Dermatol; 2024 Apr; 63(4):547-548. PubMed ID: 38228398
[No Abstract] [Full Text] [Related]
10. Successful treatment of acrodermatitis continua of Hallopeau by TYK2 inhibitor with every other day.
Kan Y; Uhara H
J Dermatolog Treat; 2024 Dec; 35(1):2316239. PubMed ID: 38387442
[No Abstract] [Full Text] [Related]
11. Nail psoriasis: clinical features, pathogenesis, differential diagnoses, and management.
Haneke E
Psoriasis (Auckl); 2017; 7():51-63. PubMed ID: 29387608
[TBL] [Abstract][Full Text] [Related]
12. Atezolizumab-Induced Acrodermatitis and Pustular Psoriasis in a Patient with Non-Small Cell Lung Cancer: A Rare Case Report.
Fattore D; Esposito G; Carangelo L; Luciano MA; Megna M
Case Rep Dermatol; 2024; 16(1):42-46. PubMed ID: 38384677
[TBL] [Abstract][Full Text] [Related]
13. Ixekizumab for the Treatment of Acrodermatitis Continua of Hallopeau and Inverse Psoriasis.
Xia RY; Liu J; Chen DD; Diao ZY; Gao YM; Yin ZQ
Indian J Dermatol; 2023; 68(2):234. PubMed ID: 37275799
[No Abstract] [Full Text] [Related]
14. Acrodermatitis Perstans: ? Pustular Psoriasis.
Brain RT
Proc R Soc Med; 1935 Sep; 28(11):1534. PubMed ID: 19990448
[No Abstract] [Full Text] [Related]
15. Psoriasis in skin of color: epidemiology, genetics, clinical presentation, and treatment nuances.
Alexis AF; Blackcloud P
J Clin Aesthet Dermatol; 2014 Nov; 7(11):16-24. PubMed ID: 25489378
[No Abstract] [Full Text] [Related]
16. Atypical Psoriasis of Axillæ, with a Remarkable Family History of Psoriasis.
Weber FP; Lauber HK
Proc R Soc Med; 1939 Oct; 32(12):1583-4. PubMed ID: 19992154
[No Abstract] [Full Text] [Related]
17. Two cases of generalized pustular psoriasis: successful treatment with infliximab.
Kim HS; You HS; Cho HH; Kim WJ; Mun JH; Song M; Ko HC; Kim MB; Kim BS
Ann Dermatol; 2014 Dec; 26(6):787-8. PubMed ID: 25473247
[No Abstract] [Full Text] [Related]
18. Acrodermatitis continua of Hallopeau treated successfully with ustekinumab and acitretin after failure of tumour necrosis factor blockade and anakinra.
Saunier J; Debarbieux S; Jullien D; Garnier L; Dalle S; Thomas L
Dermatology; 2015; 230(2):97-100. PubMed ID: 25471551
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of adalimumab and methotrexate combination therapy on generalized pustular psoriasis patients unresponsive to infliximab monotherapy due to anti-infliximab antibody development.
Kawakami H; Maeda T; Abe N; Matsumoto Y; Mitsuhashi Y; Tsuboi R; Okubo Y
J Dermatol; 2015 Jan; 42(1):94-5. PubMed ID: 25425479
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
